Payment & Shipping Terms:
|Product name:||Nordictropin||Specification::||10iu/vial, 10vials/kit, 100iu/kit|
|Payment Terms::||Western Union, Moneygram, T/T||Kigtropin Half Life::||2-3hours|
|Kigtropin Dosage::||4-5iu Per Day||Blood Serum Level ::||30-35|
|Market:||Global||Usage:||Hgh Injections For Weight Loss|
120iu HGH Growth Hormone Supplements,
SGA HGH Growth Hormone Supplements
Nordictropin products must be refrigerated (36°F to 46°F) prior to first use.
Do not freeze and avoid direct light. After first injection, Norditropin pens can either be stored outside of the refrigerator (up to 77°F) for use within 3 weeks, or in the refrigerator (between 36°F and 46°F) for use within 4 weeks.
Norditropin is a polypeptide hormone of recombinant DNA origin. The hormone is synthesized by a special strain of E. coli bacteria that has been modified by the addition of a plasmid which carries the gene for human growth hormone. Norditropin contains the identical sequence of 191 amino acids constituting the naturally occurring pituitary human growth hormone with a molecular weight of about 22,000 Daltons.
Norditropin cartridges are supplied as sterile solutions for subcutaneous injection in ready-to-administer cartridges or prefilled pens with a volume of 1.5 mL or 3 mL.
Do not use Norditropin® (somatropin [rDNA origin] injection) if: you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing (respiratory) problems; you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea; you have cancer or other tumors; your healthcare provider tells you that you have certain types of eye problems caused by diabetes; you are a child with closed bone growth plates (epiphyses) or you are allergic to any of the ingredients in the medicine.
Before you take Norditropin® tell your healthcare provider if you: have diabetes; had cancer or any tumor; have any other medical condition; are pregnant or plan to become pregnant; are breast-feeding or plan to breast-feed.
NORDITROPIN is indicated for the treatment of pediatric patients with:
growth failure due to inadequate secretion of endogenous growth hormone (GH),
short stature associated with Noonan syndrome,
short stature associated with Turner syndrome,
short stature born small for gestational age (SGA) with no catch-up growth by age 2 years to 4 years of age,
Idiopathic Short Stature (ISS), height standard deviation score (SDS) <-2.25, and associated with growth rates unlikely to permit attainment of adult height in the normal range,
growth failure due to Prader-Willi syndrome (PWS).
Contact Person: Gavin Lee